Are metabolic checkpoints a new way to treat intervertebral disc degeneration?

Intervertebral disc degeneration (IDD) is a primary cause of low back pain. Current medical treatments for IDD are often palliative, meaning they manage symptoms like pain but do not stop or reverse the physical breakdown of the disc tissue ⁴.

What the research says

Researchers are exploring new ways to treat the underlying causes of disc degeneration by looking at how cells respond to their environment. One proposed shift is moving away from just suppressing inflammation and toward modulating the 'microenvironment' of the disc. This includes targeting metabolic checkpoints, which are points in a cell's metabolism that can be manipulated to stop harmful changes ².

Some research suggests that mechanical stress and low oxygen levels in the disc cause cells to undergo 'maladaptive metabolic adaptation.' This process leads to the breakdown of tissue structure ². Additionally, some studies look at how oxidative stress and a process called ferroptosis (a type of cell death) contribute to the degradation of the disc's matrix ³. Other research focuses on cellular senescence, where old or damaged cells create an environment that promotes further decay. These researchers are investigating ways to clear these aged cells or use epigenetic remodeling to potentially reverse the aging of the tissue ⁴⁵.

What to ask your doctor

• What are the current standard treatments for my specific type of disc degeneration?
• Are there any emerging therapies that target the underlying biology of the disc rather than just pain management?
• How does the 'microenvironment' of my spine, such as inflammation or metabolic changes, affect my long-term outlook?
• Are there clinical trials available for new treatments targeting cellular aging or metabolism in spinal conditions?